A Phase 2, Randomized, Double-blind, Controlled Study to Evaluate the Safety and Efficacy of VX-659 Combination Therapy in Subjects Aged 18 Years and Older With Cystic Fibrosis

  • Pancham, Krishna (PI)

Grants and Contracts Details

StatusFinished
Effective start/end date8/28/17 → 8/7/18